Cargando…

Video-assisted thoracoscopic treatment as two-day surgery for lung neoplasms: a propensity-matched analysis

BACKGROUND: Enhanced recovery after surgery programs have reduced complications and shortened hospital stays after lung resection. This study aimed to determine whether video-assisted thoracoscopic surgery performed as a two-day surgery for lung neoplasms was safe and cost-effective. METHODS: This r...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Guofei, Fan, Junqiang, Yu, Zipu, Chai, Ying, Zhang, Sai, Wu, Ming, Shen, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338576/
https://www.ncbi.nlm.nih.gov/pubmed/35907842
http://dx.doi.org/10.1186/s12885-022-09938-x
_version_ 1784759999696732160
author Zhang, Guofei
Fan, Junqiang
Yu, Zipu
Chai, Ying
Zhang, Sai
Wu, Ming
Shen, Gang
author_facet Zhang, Guofei
Fan, Junqiang
Yu, Zipu
Chai, Ying
Zhang, Sai
Wu, Ming
Shen, Gang
author_sort Zhang, Guofei
collection PubMed
description BACKGROUND: Enhanced recovery after surgery programs have reduced complications and shortened hospital stays after lung resection. This study aimed to determine whether video-assisted thoracoscopic surgery performed as a two-day surgery for lung neoplasms was safe and cost-effective. METHODS: This retrospective, propensity-matched, cohort analysis was conducted from January 2020 to August 2020. Among 959 patients who underwent video-assisted thoracoscopic surgery, 739 underwent inpatient surgery and 220 underwent two-day surgery. Propensity-matched analysis, incorporating preoperative variables, was used to compare postoperative complications, post-discharge follow-up results, and hospitalization costs between the groups. RESULTS: Propensity matching estimated 218 patients in each group. The mean length of hospital stay was shorter in the two-day surgery group (2.17 ± 0.89 days) than in the inpatient surgery group (6.31 ± 2.13 days) (P < 0.001). Delayed removal of chest tubes accounted for over half of the delayed discharges in the inpatient (17 [54.8%]) and two-day surgery (13 [65.0%]) groups. The postoperative pneumonia/atelectasis incidence was lower in the two-day surgery group than in the inpatient surgery group (P = 0.032). The two-day surgery group patients were readmitted to the hospital due to massive pleural effusion, pneumothorax, fever, severe chest pain, and physical weakness. The mean total hospitalization cost in the two-day surgery group was lower than that in the inpatient surgery group (¥ 33,926.1 versus ¥ 38,422.7, P < 0.001). Basic medical, nursing, drug, laboratory-related, and nonsurgical consumable costs in the two-day surgery group were significantly reduced. CONCLUSIONS: Two-day surgery is a safe, feasible, and cost-effective procedure for selected patients with lung neoplasms when combined with accurate preoperative evaluations, successful intraoperative assessments, and effective postoperative health care guidance. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-022-09938-x.
format Online
Article
Text
id pubmed-9338576
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-93385762022-07-31 Video-assisted thoracoscopic treatment as two-day surgery for lung neoplasms: a propensity-matched analysis Zhang, Guofei Fan, Junqiang Yu, Zipu Chai, Ying Zhang, Sai Wu, Ming Shen, Gang BMC Cancer Research BACKGROUND: Enhanced recovery after surgery programs have reduced complications and shortened hospital stays after lung resection. This study aimed to determine whether video-assisted thoracoscopic surgery performed as a two-day surgery for lung neoplasms was safe and cost-effective. METHODS: This retrospective, propensity-matched, cohort analysis was conducted from January 2020 to August 2020. Among 959 patients who underwent video-assisted thoracoscopic surgery, 739 underwent inpatient surgery and 220 underwent two-day surgery. Propensity-matched analysis, incorporating preoperative variables, was used to compare postoperative complications, post-discharge follow-up results, and hospitalization costs between the groups. RESULTS: Propensity matching estimated 218 patients in each group. The mean length of hospital stay was shorter in the two-day surgery group (2.17 ± 0.89 days) than in the inpatient surgery group (6.31 ± 2.13 days) (P < 0.001). Delayed removal of chest tubes accounted for over half of the delayed discharges in the inpatient (17 [54.8%]) and two-day surgery (13 [65.0%]) groups. The postoperative pneumonia/atelectasis incidence was lower in the two-day surgery group than in the inpatient surgery group (P = 0.032). The two-day surgery group patients were readmitted to the hospital due to massive pleural effusion, pneumothorax, fever, severe chest pain, and physical weakness. The mean total hospitalization cost in the two-day surgery group was lower than that in the inpatient surgery group (¥ 33,926.1 versus ¥ 38,422.7, P < 0.001). Basic medical, nursing, drug, laboratory-related, and nonsurgical consumable costs in the two-day surgery group were significantly reduced. CONCLUSIONS: Two-day surgery is a safe, feasible, and cost-effective procedure for selected patients with lung neoplasms when combined with accurate preoperative evaluations, successful intraoperative assessments, and effective postoperative health care guidance. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-022-09938-x. BioMed Central 2022-07-30 /pmc/articles/PMC9338576/ /pubmed/35907842 http://dx.doi.org/10.1186/s12885-022-09938-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Zhang, Guofei
Fan, Junqiang
Yu, Zipu
Chai, Ying
Zhang, Sai
Wu, Ming
Shen, Gang
Video-assisted thoracoscopic treatment as two-day surgery for lung neoplasms: a propensity-matched analysis
title Video-assisted thoracoscopic treatment as two-day surgery for lung neoplasms: a propensity-matched analysis
title_full Video-assisted thoracoscopic treatment as two-day surgery for lung neoplasms: a propensity-matched analysis
title_fullStr Video-assisted thoracoscopic treatment as two-day surgery for lung neoplasms: a propensity-matched analysis
title_full_unstemmed Video-assisted thoracoscopic treatment as two-day surgery for lung neoplasms: a propensity-matched analysis
title_short Video-assisted thoracoscopic treatment as two-day surgery for lung neoplasms: a propensity-matched analysis
title_sort video-assisted thoracoscopic treatment as two-day surgery for lung neoplasms: a propensity-matched analysis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338576/
https://www.ncbi.nlm.nih.gov/pubmed/35907842
http://dx.doi.org/10.1186/s12885-022-09938-x
work_keys_str_mv AT zhangguofei videoassistedthoracoscopictreatmentastwodaysurgeryforlungneoplasmsapropensitymatchedanalysis
AT fanjunqiang videoassistedthoracoscopictreatmentastwodaysurgeryforlungneoplasmsapropensitymatchedanalysis
AT yuzipu videoassistedthoracoscopictreatmentastwodaysurgeryforlungneoplasmsapropensitymatchedanalysis
AT chaiying videoassistedthoracoscopictreatmentastwodaysurgeryforlungneoplasmsapropensitymatchedanalysis
AT zhangsai videoassistedthoracoscopictreatmentastwodaysurgeryforlungneoplasmsapropensitymatchedanalysis
AT wuming videoassistedthoracoscopictreatmentastwodaysurgeryforlungneoplasmsapropensitymatchedanalysis
AT shengang videoassistedthoracoscopictreatmentastwodaysurgeryforlungneoplasmsapropensitymatchedanalysis